October 2016

ExecuPharm Holding Company Completes Sale to PAREXEL

United States - Pennsylvania

ExecuPharm Holding Company Inc., a leading, global functional service provider (FSP) serving the biopharmaceutical industry, completed the sale of 100% of its company stock to PAREXEL International Corp., a publicly-traded strategic buyer. Our firm represented ExecuPharm Holding Company in the transaction.

Related Legal Services

Related Industries

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.